#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic mastocytosis Mantle cell lymphoma stage II Arginase deficiency Lymphangiosarcoma Growth hormone deficiency Fusarium infection Spina bifida Chronic lymphocytic leukaemia Ureteric cancer Heavy menstrual bleeding Acute leukaemia Amyloidosis Neuroendocrine carcinoma of the skin Hyperinsulinism Retinopathy proliferative More trials…

    Learn about Rare Diseases

    Usher’s syndrome – Trials in Disease Angelman’s syndrome – Trials in Disease Aicardi-Goutieres syndrome – Trials in Disease Gaucher’s disease type III – Life with Disease Antithrombin III deficiency – Treatment Rhabdomyosarcoma – Life with Disease SAPHO syndrome – Basic Information Haemophilia B with anti factor IX – Life with Disease Fragile X syndrome Richter’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pbf-999 ATIGOTATUG Recombinant Interferon Beta-1B Filgrastim ALXN2420 Casimersen MORPHINE Rbl015.2 LUXDEGALUTAMIDE Zoledronic Acid Adct-402 Resatorvid Darunavir Flecainide Sot102 Syn2 Avatrombopag Desogestrel Ibrexafungerp Nitrofurantoin More therapies…

    Learn about Your Condition

    Wolfram syndrome Diffuse large B-cell lymphoma Penile cancer Chronic lymphocytic leukaemia Extraskeletal ossification Fabry's disease Hodgkin's disease refractory Bipolar disorder Medulloblastoma recurrent Polyneuropathy Pancreatic failure Rhabdoid tumour of the kidney Mesothelioma malignant Cardiovascular disorder Laryngeal cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Bacs-Kiskun Varmegyei Oktatokorhaz

Bacs-Kiskun Varmegyei Oktatokorhaz

Nyiri Ut 38, Kecskemet, 6000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Vibostolimab
    • Atezolizumab
    • Carboplatin
    Austria Finland France Germany Greece Hungary +8

  • Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Quavonlimab
    • Belzutifan
    • Lenvatinib
    Croatia Czechia Denmark Finland France Germany +8

  • Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Quavonlimab
    • Favezelimab
    • Mk-4830
    Belgium Denmark Estonia France Germany Greece +7

  • Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Abemaciclib
    • Fulvestrant
    Belgium Czechia Denmark France Greece Hungary +3

  • Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Gemcitabine
    France Germany Hungary Ireland Poland Spain
Previous Page
1 … 11 12 13

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!